These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 25029906

  • 21. Astrocyte-elevated gene-1 overexpression is associated with poor prognosis in gastric cancer.
    Jian-bo X, Hui W, Yu-long H, Chang-hua Z, Long-juan Z, Shi-rong C, Wen-hua Z.
    Med Oncol; 2011 Jun; 28(2):455-62. PubMed ID: 20300973
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Sites of distant metastases and the cancer-specific survival of metastatic Siewert type II esophagogastric junction adenocarcinoma: a population-based study.
    Chen K, Deng X, Yang Z, Yu D, Zhang X, Li W, Xie D, He Z, Cheng D.
    Expert Rev Gastroenterol Hepatol; 2020 Jun; 14(6):491-497. PubMed ID: 32324423
    [Abstract] [Full Text] [Related]

  • 27. Lymphangiogenesis and prognostic significance of vascular endothelial growth factor C in gastro-oesophageal junction adenocarcinoma.
    Xie LX, Zhai TT, Yang LP, Yang E, Zhang XH, Chen JY, Zhang H.
    Int J Exp Pathol; 2013 Feb; 94(1):39-46. PubMed ID: 23317352
    [Abstract] [Full Text] [Related]

  • 28. The prognostic significance of WNT pathway in surgically-treated colorectal cancer: β-catenin expression predicts for disease-free survival.
    Kamposioras K, Konstantara A, Kotoula V, Lakis S, Kouvatseas G, Akriviadis E, Vrettou E, Dionysopoulos D, Krikelis D, Papadopoulou K, Charalambous E, Chrisafi S, Konstantaras C, Fountzilas G.
    Anticancer Res; 2013 Oct; 33(10):4573-84. PubMed ID: 24123033
    [Abstract] [Full Text] [Related]

  • 29. Molecular correlates and prognostic significance of SATB1 expression in colorectal cancer.
    Nodin B, Johannesson H, Wangefjord S, O'Connor DP, Lindquist KE, Uhlén M, Jirström K, Eberhard J.
    Diagn Pathol; 2012 Aug 30; 7():115. PubMed ID: 22935204
    [Abstract] [Full Text] [Related]

  • 30. Expression of β-catenin and its correlation with metastatic progression of esophagogastric junction adenocarcinoma.
    Wlodarczyk J, Rudnicka-Sosin L, Kużdżał J.
    Pol J Pathol; 2015 Dec 30; 66(4):414-9. PubMed ID: 27003775
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Extranodal metastasis is a powerful prognostic factor in patients with adenocarcinoma of the esophagogastric junction.
    Zhang HD, Tang P, Duan XF, Chen CG, Ma Z, Gao YY, Zhang H, Yu ZT.
    J Surg Oncol; 2013 Dec 30; 108(8):542-9. PubMed ID: 24018956
    [Abstract] [Full Text] [Related]

  • 34. Associations of beta-catenin alterations and MSI screening status with expression of key cell cycle regulating proteins and survival from colorectal cancer.
    Wangefjord S, Brändstedt J, Lindquist KE, Nodin B, Jirström K, Eberhard J.
    Diagn Pathol; 2013 Jan 21; 8():10. PubMed ID: 23337059
    [Abstract] [Full Text] [Related]

  • 35. [Adenocarcinoma of the esophagogastric junction: prognostic factors and results of primary surgery].
    Bösing NM, Heise JW, Goretzki PE, Sarbia M, Röher HD.
    Chirurg; 2004 Nov 21; 75(11):1088-97. PubMed ID: 15168031
    [Abstract] [Full Text] [Related]

  • 36. Surgical strategies in true adenocarcinoma of the esophagogastric junction (AEG II): thoracoabdominal or abdominal approach?
    Blank S, Schmidt T, Heger P, Strowitzki MJ, Sisic L, Heger U, Nienhueser H, Haag GM, Bruckner T, Mihaljevic AL, Ott K, Büchler MW, Ulrich A.
    Gastric Cancer; 2018 Mar 21; 21(2):303-314. PubMed ID: 28685209
    [Abstract] [Full Text] [Related]

  • 37. Prognostic implications of RASAL1 expression in oesophagogastric adenocarcinoma.
    Knief J, Reddemann K, Lazar-Karsten P, Herhahn T, Petrova E, Wellner U, Thorns C.
    J Clin Pathol; 2017 Mar 21; 70(3):274-276. PubMed ID: 28011578
    [No Abstract] [Full Text] [Related]

  • 38. The prognostic value of preoperative inflammation-based prognostic scores and nutritional status for overall survival in resected patients with nonmetastatic Siewert type II/III adenocarcinoma of esophagogastric junction.
    Zhang L, Su Y, Chen Z, Wei Z, Han W, Xu A.
    Medicine (Baltimore); 2017 Jul 21; 96(30):e7647. PubMed ID: 28746229
    [Abstract] [Full Text] [Related]

  • 39. Development and validation of a survival nomogram for patients with Siewert type II/III adenocarcinoma of the esophagogastric junction based on real-world data.
    Chen J, Xia YJ, Liu TY, Lai YH, Yu JS, Zhang TH, Ooi S, He YL.
    BMC Cancer; 2021 May 10; 21(1):532. PubMed ID: 33971833
    [Abstract] [Full Text] [Related]

  • 40. Prognostic significance of the location of metastatic lymph nodes in patients with adenocarcinoma of the oesophagogastric junction.
    Liu JF, Jiang T, Shi ZH, Liu XB.
    ANZ J Surg; 2018 Mar 10; 88(3):218-222. PubMed ID: 27444989
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.